SCHEMBL925036

SCHEMBL925036

CCCCCCCCCCCCCCCC(=O)OCc1ccco1

nearest known ligand 0.74

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
ELANE P08246 10/20 0.56
EGFR P00533 1/20 0.49
ERBB2 P04626 1/20 0.49
DGKA P23743 1/20 0.49
PAM P19021 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30152013 1.00 ALDH1A1 (0.58) ALDH1A1ELANEEGFRERBB2DGKA
SCHEMBL30152028 1.00 ALDH1A1 (0.58) ALDH1A1ELANEEGFRERBB2DGKA
SCHEMBL5166825 1.00 ALDH1A1 (0.58) ALDH1A1ELANEEGFRERBB2DGKA
SCHEMBL2395752 1.00 ALDH1A1 (0.58) ALDH1A1ELANEEGFRERBB2DGKA
SCHEMBL18339201 1.00 ALDH1A1 (0.58) ALDH1A1ELANEEGFRERBB2DGKA
SCHEMBL8579272 0.98 ALDH1A1 (0.59) ALDH1A1ELANEEGFRERBB2DGKA
Alcohol SCHEMBL8207628 0.97 ALDH1A1 (0.55) ALDH1A1ELANEEGFRERBB2DGKA
SCHEMBL155116 0.94 ALDH1A1 (0.61) ALDH1A1ELANEEGFRERBB2
SCHEMBL11002116 0.92 ALDH1A1 (0.62) ALDH1A1ELANEEGFRERBB2
SCHEMBL11001635 0.92 ALDH1A1 (0.62) ALDH1A1ELANEEGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120171156-A1 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES HDS LTD. (GB) 2012-07-05 US claimed
EP-2442873-A2 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES Hds Limited (GB) 2012-04-25 EP claimed
WO-2010146142-A9 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES HDS LIMITED (GB) 2011-06-16 WO claimed
WO-2010146142-A2 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES HDS LIMITED (GB) 2010-12-23 WO claimed
WO-2026104886-A1 METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY 유엔케이코리아 주식회사 2026-05-21 WO disclosed
CN-120349592-B High-toughness composite recycled plastic and preparation method thereof 辽宁双巍环保科技有限责任公司 2026-01-23 CN disclosed
CN-120349592-A High-toughness composite recycled plastic and preparation method thereof 辽宁双巍环保科技有限责任公司 2025-07-22 CN disclosed
US-12350352-B2 Composition for surface modification LG HOUSEHOLD & HEALTH CARE LTD. (KR) 2025-07-08 US disclosed
EP-3342395-B1 COMPOSITION FOR HAIR SURFACE MODIFICATION LG HOUSEHOLD & HEALTH CARE LTD (KR) 2024-08-07 EP disclosed
EP-4406617-A2 COMPOSITION FOR SURFACE MODIFICATION LG Household & Health Care Ltd. (KR) 2024-07-31 EP disclosed
EP-2968157-B1 FINE DRY PARTICULATE RETINOID ACTIVE AGENT COMPOSITIONS AND TOPICAL FORMULATIONS INCLUDING THE SAME LABORATORY SKIN CARE INC (US) 2023-11-08 EP disclosed
CN-116490598-A Detergent compositions with enhanced efficacy delivery of substances 株式会社LG生活健康 2023-07-25 CN disclosed
WO-2008134712-A2 USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE LIVING PROOF, INC. (US) 2008-11-06 WO disclosed
WO-2008070368-A2 METHODS AND COMPOSITIONS FOR SKIN CARE LIVING PROOF, INC. (US) 2008-06-12 WO disclosed
US-7371396-B2 Dermatological and cosmetic compositions RELIVIA SRL (IT) 2008-05-13 US disclosed
EP-1392282-B1 DERMATOLOGICAL AND COSMETIC COMPOSITIONS COMPRISING A FURFURYL DERIVATIVE RELIVIA SRL (IT) 2008-02-06 EP disclosed
US-20040127554-A1 Dermatological and cosmetic compositions RELIVIA SRL (IT) 2004-07-01 US disclosed
EP-1392282-A2 DERMATOLOGICAL AND COSMETIC COMPOSITIONS Ghisalberti, Carlo (BR) 2004-03-03 EP disclosed
WO-2003075913-A1 TOPICAL COMPOSTIONS COMPRISING FURFURYL DERIVATIVES AND THEIR USE FOR THE TREATMENT OF DERMATOLOGIC DISORDERS GHISALBERTI CARLO (BR) 2003-09-18 WO disclosed
WO-2002092026-A2 DERMATOLOGICAL AND COSMETIC COMPOSITIONS GHISALBERTI CARLO (BR) 2002-11-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12350352-B2 Composition for surface modification CUTA, PTMS, DNMT1 ALDH1A1 1329/4885ELANE 3438/4885EGFR 180/4885
US-20040127554-A1 Dermatological and cosmetic compositions SUCLG1, CUTA, TYR ALDH1A1 11/4885ELANE 708/4885EGFR 3115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.